Skip to main content
Online First
FDA Updates
Atezolizumab First PD-L1 Inhibitor Approved for the Treatment of Patients with Metastatic NSCLC
Read More
The Importance of Monitoring Cardiotoxicity in Patients with Breast Cancer
Sandra Cuellar Puri, PharmD, BCOP
Read More
Original Research
The Effect of Written Pharmacist-Provided Patient Education for 3 Frequently Prescribed Oral Anticancer Agents on the Incidence of Patient-Initiated Triage Calls
Nicolas De Padova, PharmD, Robert Grabowski, PharmD, Joseph Ineck, PharmD, CPE, Robert Mancini, PharmD, BCOP, FHOPA
Read More
Supportive Care
HER2 Receptor Antagonist–Associated Cardiotoxicity
Alison Palumbo, PharmD, MPH, BCOP, Joseph Bubalo, PharmD, BCPS, BCOP
Read More
Overview of the Current Treatment Paradigm in Chronic Lymphocytic Leukemia, Part 2
Austin J. Combest, PharmD, BCOP, MBA, Ryan C. Danford, PharmD, Elizabeth R. Andrews, PharmD, Ashley Simmons, PharmD, Paulina McAtee, PharmD, Dirk J. Reitsma, MD
Read More
Lung Cancer
Adjusted Dosing and Schedule of Pemetrexed in Impaired Renal Function
Zahava Ohana, PharmD, Amanda Brahim, PharmD, BCPS, Mohammed Ibrahim, RPh, BCOP, BCPS, BCACP
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
FDA Updates
Pembrolizumab Approved for Patients with Head and Neck Cancer
Read More
Original Research
Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib
Justin Arnall, PharmD, BCOP, CPP
Read More
Cyanocobalamin/Salcaprozate Sodium: A Novel Way to Treat Vitamin B12 Deficiency and Anemia
Lillian Smith, PharmD, MBA, CPh, Juan Mosley, PharmD, CPh, AAHIVP, Megan Ford, PharmDc, Jonathan Courtney, PharmDc
Read More
Page 172 of 200
Results 1711 - 1720 of 1993